Free Trial

Viracta Therapeutics (VIRX) Short Interest Ratio & Short Volume

Viracta Therapeutics logo
$0.0098 0.00 (0.00%)
As of 07/24/2025

Viracta Therapeutics Short Interest Data

Viracta Therapeutics (VIRX) has a short interest of 8,100 shares, representing 0.02% of the float (the number of shares available for trading by the public). This marks a -41.73% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 1.11 million shares to cover all short positions.

Current Short Interest
8,100 shares
Previous Short Interest
13,900 shares
Change Vs. Previous Month
-41.73%
Dollar Volume Sold Short
$134.46
Short Interest Ratio
0.0 Days to Cover
Last Record Date
June 30, 2025
Outstanding Shares
39,744,000 shares
Short Percent of Float
0.02%
Today's Trading Volume
0 shares
Average Trading Volume
1,111,440 shares
Today's Volume Vs. Average
0%
Short Selling Viracta Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Viracta Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

VIRX Short Interest Over Time

VIRX Days to Cover Over Time

VIRX Percentage of Float Shorted Over Time

Viracta Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/20258,100 shares $134.46 -41.7%0.0%0 $0.02
6/15/202513,900 shares $243.25 -38.5%0.0%0.1 $0.02
5/31/202522,600 shares $413.58 -23.1%0.1%0.1 $0.02
5/15/202529,400 shares $514.50 -26.3%N/A0.2 $0.02
4/30/202539,900 shares $833.91 +405.1%N/A0.3 $0.02
4/15/20257,900 shares $132.72 -21.0%N/A0 $0.02
3/14/202528,200 shares $733.20 +108.9%N/A0 $0.03
2/14/202523,200 shares $396.72 -87.4%N/A0 $0.02
1/31/2025184,200 shares $27.91 thousand -25.1%0.7%0.1 $0.15
1/15/2025246,000 shares $40.34 thousand -59.7%0.9%0.1 $0.16
12/31/2024609,900 shares $98.13 thousand -79.7%2.2%0.2 $0.16
12/15/20243,000,000 shares $608.10 thousand +89.9%10.7%1.4 $0.20
11/30/20241,580,000 shares $221.20 thousand -24.8%5.7%0.8 $0.14
11/15/20242,100,000 shares $317.10 thousand -21.9%7.5%2 $0.15
10/31/20242,690,000 shares $542.84 thousand +144.6%9.7%1.9 $0.20
10/15/20241,100,000 shares $241.56 thousand -17.3%4.0%1.7 $0.22
9/30/20241,330,000 shares $307.76 thousand +1.5%4.8%2.1 $0.23
9/15/20241,310,000 shares $328.81 thousand +4.0%4.7%2.1 $0.25
8/31/20241,260,000 shares $269.14 thousand -50.4%4.6%2.1 $0.21
8/15/20242,540,000 shares $885.19 thousand +178.5%9.2%4.8 $0.35
7/31/2024912,000 shares $436.85 thousand -6.4%3.3%8.5 $0.48
7/15/2024974,800 shares $517.62 thousand +35.2%3.5%10.7 $0.53
6/30/2024721,000 shares $392.01 thousand +1.7%2.6%7 $0.54
6/15/2024708,900 shares $477.66 thousand +3.8%2.6%6.7 $0.67
5/31/2024682,700 shares $477.89 thousand +2.1%2.5%6.3 $0.70
5/15/2024668,400 shares $561.46 thousand -4.4%2.4%6.5 $0.84
4/30/2024699,400 shares $573.23 thousand +1.9%2.5%6.3 $0.82
4/15/2024686,700 shares $535.63 thousand +6.0%2.5%6.2 $0.78
3/31/2024648,000 shares $660.96 thousand +2.2%2.4%6.8 $1.02
3/15/2024634,300 shares $631.76 thousand -7.1%2.3%5.7 $1.00
2/29/2024683,000 shares $556.65 thousand +0.6%2.5%5 $0.82
2/15/2024678,800 shares $433.75 thousand +4.5%2.5%4.5 $0.64
1/31/2024649,900 shares $370.44 thousand +0.4%2.4%4 $0.57
1/15/2024647,500 shares $384.23 thousand -1.9%2.4%3.8 $0.59
12/31/2023660,300 shares $376.37 thousand -14.9%2.5%3.8 $0.57
12/15/2023776,100 shares $361.97 thousand +19.3%2.9%4.6 $0.47
11/30/2023650,700 shares $316.89 thousand -8.2%2.4%4.9 $0.49
11/15/2023708,700 shares $425.50 thousand +3.0%2.6%7.3 $0.60
10/31/2023688,200 shares $424.28 thousand +12.0%2.6%7.5 $0.62
10/15/2023614,700 shares $436.44 thousand -2.7%2.3%7.6 $0.71
Is this the biggest winner of Trump’s tariffs? (Ad)

America’s industrial comeback is underway — and it’s bigger than anyone expected. Over $5 trillion has already been pledged to restore U.S. manufacturing. Trump’s tariffs and trade pressure have set off a massive reshoring push, and the flood of investment is still gaining steam. But while everyone’s watching the big names, one under-the-radar company holds the key tech that could make it all work — and potentially benefit the most.

This could be the #1 America First stock of the decade.
9/30/2023632,000 shares $657.28 thousand -4.3%2.4%7 $1.04
9/15/2023660,200 shares $838.45 thousand -5.3%2.5%7.8 $1.27
8/31/2023697,200 shares $1.00 million -4.4%2.6%6.8 $1.44
8/15/2023729,100 shares $947.83 thousand +5.2%2.7%4.5 $1.30
7/31/2023692,900 shares $1.07 million -3.9%2.6%2.8 $1.55
7/15/2023721,000 shares $1.05 million -1.0%2.7%2.9 $1.45
6/30/2023728,500 shares $1.03 million -7.8%2.8%3 $1.41
6/15/2023789,900 shares $1.26 million +14.0%3.0%3.3 $1.59
5/31/2023693,200 shares $921.96 thousand +12.4%2.6%3.2 $1.33
5/15/2023616,700 shares $807.88 thousand -2.2%2.3%3.4 $1.31
4/30/2023630,800 shares $813.73 thousand +2.0%2.4%8.4 $1.29
4/15/2023618,300 shares $902.72 thousand -2.5%2.3%9.6 $1.46
3/31/2023634,000 shares $1.01 million -19.5%2.4%8.4 $1.59
3/15/2023787,800 shares $1.33 million +51.7%3.0%8.7 $1.69
2/28/2023519,200 shares $882.64 thousand +3.9%2.0%4.9 $1.70
2/15/2023499,500 shares $994.01 thousand +5.6%1.9%4.5 $1.99
1/31/2023473,000 shares $983.84 thousand -2.5%1.8%3.8 $2.08
1/15/2023485,300 shares $1.10 million +3.2%1.8%3.9 $2.26
12/30/2022470,300 shares $686.64 thousand -15.1%1.8%3.8 $1.46
12/15/2022553,600 shares $1.06 million -0.1%2.1%5.2 $1.92
11/30/2022553,900 shares $1.29 million +7.3%2.1%5.1 $2.32
11/15/2022516,200 shares $1.50 million +8.8%2.0%4.8 $2.90
10/31/2022474,600 shares $1.87 million -9.6%1.9%4.7 $3.93
10/15/2022525,100 shares $1.97 million -4.4%2.0%5.1 $3.75
9/30/2022549,000 shares $2.34 million +9.3%2.1%5 $4.27
9/15/2022502,100 shares $2.81 million -3.9%2.0%2.6 $5.59
8/31/2022522,300 shares $2.12 million +0.6%2.0%2.3 $4.05
8/15/2022519,100 shares $2.29 million -8.2%2.0%2.2 $4.42
7/31/2022565,400 shares $1.88 million -16.1%1.9%2.2 $3.32
7/15/2022673,800 shares $2.99 million -32.5%2.3%2.5 $4.44
6/30/2022998,500 shares $3.87 million -48.5%3.4%3.2 $3.88
6/15/20221,940,000 shares $4.85 million -3.0%6.5%6.1 $2.50
5/31/20222,000,000 shares $4.24 million +8.7%6.7%8.1 $2.12
5/15/20221,840,000 shares $3.44 million -7.1%6.2%7.3 $1.87
4/30/20221,980,000 shares $5.05 million +16.5%6.7%6.2 $2.55
4/15/20221,700,000 shares $6.90 million +20.6%5.7%5.2 $4.06
3/31/20221,410,000 shares $6.71 million +20.5%4.8%4.7 $4.76
3/15/20221,170,000 shares $2.61 million +13.6%3.9%4.2 $2.23
2/28/20221,030,000 shares $2.81 million +7.8%3.5%3.5 $2.73
2/15/2022955,900 shares $2.98 million +26.0%3.2%3 $3.12
1/31/2022758,800 shares $2.03 million +5.5%2.7%2.9 $2.68
1/15/2022719,100 shares $2.28 million -15.4%2.5%3.3 $3.17
12/31/2021849,800 shares $3.10 million -2.7%3.0%3.7 $3.65
12/15/2021873,100 shares $3.12 million +30.4%3.1%4 $3.57
11/30/2021669,400 shares $3.09 million -24.3%2.4%3.8 $4.61
11/15/2021884,500 shares $4.93 million -15.0%3.1%5.5 $5.57
10/29/20211,040,000 shares $6.12 million -7.1%3.5%6.6 $5.88
10/15/20211,120,000 shares $7.25 million -1.8%3.8%7.5 $6.47
9/30/20211,140,000 shares $9.14 million -5.0%3.8%8.5 $8.02
9/15/20211,200,000 shares $10.08 million -9.1%4.0%5.5 $8.40
Is this the biggest winner of Trump’s tariffs? (Ad)

America’s industrial comeback is underway — and it’s bigger than anyone expected. Over $5 trillion has already been pledged to restore U.S. manufacturing. Trump’s tariffs and trade pressure have set off a massive reshoring push, and the flood of investment is still gaining steam. But while everyone’s watching the big names, one under-the-radar company holds the key tech that could make it all work — and potentially benefit the most.

This could be the #1 America First stock of the decade.
8/31/20211,320,000 shares $12.17 million -15.9%4.4%4.9 $9.22
8/13/20211,570,000 shares $16.11 million No Change5.3%5.7 $10.26

VIRX Short Interest - Frequently Asked Questions

What is Viracta Therapeutics' current short interest?

Short interest is the volume of Viracta Therapeutics shares that have been sold short but have not yet been closed out or covered. As of June 30th, investors have sold 8,100 shares of VIRX short. 0.02% of Viracta Therapeutics' shares are currently sold short. Learn More on Viracta Therapeutics' current short interest.

What is a good short interest percentage for Viracta Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.02% of Viracta Therapeutics' floating shares are currently sold short.

Is Viracta Therapeutics' short interest increasing or decreasing?

Viracta Therapeutics saw a drop in short interest in June. As of June 30th, there was short interest totaling 8,100 shares, a drop of 41.7% from the previous total of 13,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Viracta Therapeutics' short interest compare to its competitors?

0.02% of Viracta Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Viracta Therapeutics: Salarius Pharmaceuticals, Inc. (33.45%), Bio-Path Holdings, Inc. (0.10%), Avenue Therapeutics, Inc. (2.48%), Oragenics, Inc. (45.59%), Panbela Therapeutics, Inc. (0.00%), Evofem Biosciences, Inc. (0.03%), Trevena, Inc. (0.38%), Petros Pharmaceuticals, Inc. (3.74%), Syros Pharmaceuticals, Inc. (0.51%), Sorrento Therapeutics, Inc. (0.67%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks.

What does it mean to sell short Viracta Therapeutics stock?

Short selling VIRX is an investing strategy that aims to generate trading profit from Viracta Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Viracta Therapeutics?

A short squeeze for Viracta Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VIRX, which in turn drives the price of the stock up even further.

How often is Viracta Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VIRX, twice per month. The most recent reporting period available is June, 30 2025.




This page (NASDAQ:VIRX) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners